Trials / Completed
CompletedNCT00036127
Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Study to learn if the alternate formulation is effective in agitated schizophrenic patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | aripiprazole |
Timeline
- Start date
- 2002-04-01
- Primary completion
- 2003-01-01
- Completion
- 2003-01-01
- First posted
- 2002-05-09
- Last updated
- 2013-11-11
Locations
16 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00036127. Inclusion in this directory is not an endorsement.